Please use this identifier to cite or link to this item: http://hdl.handle.net/1942/42716
Full metadata record
DC FieldValueLanguage
dc.contributor.authorSTANDAERT, Baudouin-
dc.date.accessioned2024-03-27T14:04:37Z-
dc.date.available2024-03-27T14:04:37Z-
dc.date.issued2023-
dc.date.submitted2024-03-27T12:17:13Z-
dc.identifier.citationVaccines, 11 (11) (Art N° 1646)-
dc.identifier.urihttp://hdl.handle.net/1942/42716-
dc.description.abstractPresently, there are at least five important vaccine producers that have already launched or intend to launch a new vaccine designed to prevent infections caused by the Respiratory Syncytial Virus (RSV), which is highly prevalent in the youngest as well as the oldest age groups [...].-
dc.language.isoen-
dc.publisherMDPI-
dc.rights2023 by the author. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https:// creativecommons.org/licenses/by/ 4.0/).-
dc.titleComment on Postma et al. Predicted Public Health and Economic Impact of Respiratory Syncytial Virus Vaccination with Variable Duration of Protection for Adults ≥60 Years in Belgium. Vaccines 2023, 11, 990-
dc.typeJournal Contribution-
dc.identifier.issue11-
dc.identifier.volume11-
local.format.pages6-
local.bibliographicCitation.jcatA2-
dc.description.notesStandaert, B (corresponding author), Univ Hasselt, Fac Med & Life Sci, Dept Care & Eth, B-3590 Diepenbeek, Belgium.; Standaert, B (corresponding author), HEBO Bv, B-2020 Antwerp, Belgium.-
dc.description.notesbaudouin.standaert@uhasselt.be-
local.publisher.placeST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND-
local.type.refereedRefereed-
local.type.specifiedEditorial Material-
local.bibliographicCitation.artnr1646-
dc.identifier.doi10.3390/vaccines11111646-
dc.identifier.pmid38005978-
dc.identifier.isiWOS:001166851400001-
dc.contributor.orcidstandaert, baudouin/0000-0001-6801-9654-
local.provider.typewosris-
local.description.affiliation[Standaert, Baudouin] Univ Hasselt, Fac Med & Life Sci, Dept Care & Eth, B-3590 Diepenbeek, Belgium.-
local.description.affiliation[Standaert, Baudouin] HEBO Bv, B-2020 Antwerp, Belgium.-
local.uhasselt.internationalno-
item.accessRightsOpen Access-
item.fullcitationSTANDAERT, Baudouin (2023) Comment on Postma et al. Predicted Public Health and Economic Impact of Respiratory Syncytial Virus Vaccination with Variable Duration of Protection for Adults ≥60 Years in Belgium. Vaccines 2023, 11, 990. In: Vaccines, 11 (11) (Art N° 1646).-
item.fulltextWith Fulltext-
item.contributorSTANDAERT, Baudouin-
crisitem.journal.eissn2076-393X-
Appears in Collections:Research publications
Files in This Item:
File Description SizeFormat 
Comment on Postma et al. Predicted Public Health and Economic Impact of Respiratory w11, 990.pdfPublished version547.61 kBAdobe PDFView/Open
Show simple item record

WEB OF SCIENCETM
Citations

1
checked on May 12, 2024

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.